PTC Therapeutics (PTCT) PT Raised to $95 at Wells Fargo
Tweet
Share
E-mailGet Alerts PTCT Hot Sheet
Price: $71.06 +1.78%
Rating Summary:
17 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 7 | New: 77
Rating Summary:
17 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 7 | New: 77
Join SI Premium – FREE
Wells Fargo analyst Ben Burnett raised the price target on PTC Therapeutics (NASDAQ: PTCT) to $95.00 (from $86.00) while maintaining a Overweight rating.
You May Also Be Interested In
- PTC Therapeutics to present Sephience PKU data at SSIEM 2026
- Jefferies Upgrades Lens Technology Co (6613:HK) to Buy
- JBS SA (JBS) PT Raised to $17.50 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
